Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections / 전남의대학술지
Chonnam Medical Journal
; : 37-44, 2014.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-55540
Responsible library:
WPRO
ABSTRACT
Carbapenem-resistant Acinetobacter species are increasingly recognized as major nosocomial pathogens, especially in patients with critical illnesses or in intensive care. The ability of these organisms to accumulate diverse mechanisms of resistance limits the available therapeutic agents, makes the infection difficult to treat, and is associated with a greater risk of death. In this review, we provide an update on the epidemiology, resistance mechanisms, infection control measures, treatment, and outcomes of carbapenem-resistant Acinetobacter infections.
Full text:
Available
Health context:
SDG3 - Health and Well-Being
Health problem:
Target 3.3: End transmission of communicable diseases
Database:
WPRIM (Western Pacific)
Main subject:
Acinetobacter
/
Acinetobacter Infections
/
Epidemiology
/
Infection Control
/
Critical Illness
/
Colistin
/
Critical Care
/
Acinetobacter baumannii
/
Drug Therapy
Type of study:
Screening study
Limits:
Humans
Language:
English
Journal:
Chonnam Medical Journal
Year:
2014
Document type:
Article